Pilot, Proof-of-Concept Study of Sublingual Tizanidine in Children With Chronic Traumatic Brain Injury (TBI)

NCT00287157 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

5

Enrollment

INDUSTRY

Sponsor class

Conditions

Traumatic Brain Injury

Interventions

DRUG: Sublingual Tizanidine HCl

Sponsor

Teva GTC